428 related articles for article (PubMed ID: 21316752)
1. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).
Sandset EC; Murray G; Boysen G; Jatuzis D; Kõrv J; Lüders S; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Int J Stroke; 2010 Oct; 5(5):423-7. PubMed ID: 20854630
[TBL] [Abstract][Full Text] [Related]
3. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
[TBL] [Abstract][Full Text] [Related]
4. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
[TBL] [Abstract][Full Text] [Related]
5. Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
Jusufovic M; Sandset EC; Bath PM; Karlson BW; Berge E;
Int J Stroke; 2015 Apr; 10(3):354-9. PubMed ID: 25472578
[TBL] [Abstract][Full Text] [Related]
6. Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Jusufovic M; Sandset EC; Bath PM; Berge E;
J Hypertens; 2016 Aug; 34(8):1594-8. PubMed ID: 27228435
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke.
Jusufovic M; Sandset EC; Bath PM; Berge E;
Stroke; 2014 Nov; 45(11):3440-2. PubMed ID: 25256183
[TBL] [Abstract][Full Text] [Related]
10. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
11. Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.
Sandset EC; Jusufovic M; Sandset PM; Bath PM; Berge E;
Stroke; 2015 Mar; 46(3):877-9. PubMed ID: 25657183
[TBL] [Abstract][Full Text] [Related]
12. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.
Saxby BK; Harrington F; Wesnes KA; McKeith IG; Ford GA
Neurology; 2008 May; 70(19 Pt 2):1858-66. PubMed ID: 18458219
[TBL] [Abstract][Full Text] [Related]
13. Lowering blood pressure in acute stroke: the SCAST trial.
Hankey GJ
Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
[No Abstract] [Full Text] [Related]
14. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
[TBL] [Abstract][Full Text] [Related]
15. Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months.
Hornslien AG; Sandset EC; Wyller TB; Berge E;
J Hypertens; 2015 Jul; 33(7):1487-91. PubMed ID: 26039534
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of treating prehypertension with an angiotensin-receptor blocker.
Julius S; Nesbitt SD; Egan BM; Weber MA; Michelson EL; Kaciroti N; Black HR; Grimm RH; Messerli FH; Oparil S; Schork MA;
N Engl J Med; 2006 Apr; 354(16):1685-97. PubMed ID: 16537662
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
Fischer U; Rothwell PM
Stroke; 2011 Oct; 42(10):2995-8. PubMed ID: 21852619
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]